Performance of the EORTC questionnaire for the assessment of quality of life in head and neck cancer patients EORTC QLQ-H&N35: a methodological review
- 28 November 2012
- journal article
- review article
- Published by Springer Science and Business Media LLC in Quality of Life Research
- Vol. 22 (8), 1927-1941
- https://doi.org/10.1007/s11136-012-0325-1
Abstract
The EORTC QLQ-H&N35 (H&N35) is widely used to measure quality of life in head and neck cancer patients. The aims of this study were to obtain insight into a) the languages in which the H&N35 has been used and the psychometric properties in those languages, b) the study designs, and c) its acceptance by patients and investigators. A systematic literature review was performed searching for all original papers that had used at least one item of the H&N35. Identified papers were read and the information about methodological issues abstracted statistically analysed. A total of 136 papers were identified. The H&N35 was administered in 19 different languages in 27 countries. The study design was cross-sectional in the majority of studies (53 %), prospective cohort studies (31 %), phase-II-trials (7 %), phase-III-trials (6 %) and case–control studies (1 %). The scales with the highest percentages of missing values were Sexuality (11.5 %) and Speech (7 %). The median Cronbach’s alpha of the multi-item scales ranged from 0.61 (Senses) to 0.93 (Sexuality). Construct validity was rarely investigated. On average, 12 scales (range 0-18) of the instrument were used by the investigators. The scale most often used was swallowing (in 85 % of studies) and least often used was Weight Gain (39 %). The H&N35 is widely used throughout the world, mainly in observational studies, and has demonstrated robust psychometric features in different languages. However, some methodological problems reported imply that the instrument can be improved in some areas.This publication has 140 references indexed in Scilit:
- A decision support system for quality of life in head and neck oncology patientsHead & Neck Oncology, 2012
- Short-term health-related quality of life and symptom control with docetaxel, cisplatin, 5-fluorouracil and cisplatin (TPF), 5-fluorouracil (PF) for induction in unresectable locoregionally advanced head and neck cancer patients (EORTC 24971/TAX 323)British Journal of Cancer, 2010
- Early and long-term morbidity after total laryngopharyngectomyEuropean Archives of Oto-Rhino-Laryngology, 2010
- Impact of treatment on quality of life for oral and oropharyngeal carcinomaInternational Journal of Oral & Maxillofacial Surgery, 2009
- Importance of patient, tumour and treatment related factors on quality of life in head and neck cancer patients after definitive treatmentEuropean Archives of Oto-Rhino-Laryngology, 2008
- Self evaluation of communication experiences after laryngeal cancer – A longitudinal questionnaire study in patients with laryngeal cancerBMC Cancer, 2008
- Long-term functional outcome and satisfaction after radial forearm free flap reconstructions of intraoral malignancy resectionsJournal of Plastic, Reconstructive & Aesthetic Surgery, 2007
- Lebensqualität und Sprachverständlichkeit bei Patienten mit Kehlkopfkarzinom - Relevanz des „Zufriedenheitsparadoxes”Laryngo-Rhino-Otologie, 2007
- Prospective evaluation of quality of life after oncologic surgery for oral cancerInternational Journal of Oral & Maxillofacial Surgery, 2002
- A 12 country field study of the EORTC QLQ-C30 (version 3.0) and the head and neck cancer specific module (EORTC QLQ-H&N35) in head and neck patientsEuropean Journal of Cancer, 2000